Former executives with generic drug firms charged with anticompetitive scheme
In the first charges brought by the Justice Department’s antitrust division involving generic drugs, two ex-senior executives with generic pharmaceutical companies were charged with an anticompetitive scheme, the government said on...To view the full article, register now.
Already a subscriber? Click here to view full article